Alnylam Pharmaceuticals Inc (ALNY) Insider Trading

Total insider buys:
  • $71,277,732.32
Total insider sells:
  • $336,775,907.87
Most recent insider trade:
  • Aug. 5, 2022
Most active insider trader:
  • John Maraganore
Trader NameDateTitleAmountPriceTypeTotal Value
March 14, 2018Insider88,554$143.10Sell$12,672,077.40
March 13, 2018Director27,823$150.00Sell$4,173,450.00
March 13, 2018SVP20,000$145.00Sell$2,900,000.00
March 9, 2018Director15,000$129.00Sell$1,935,000.00
Jan. 4, 2018VP36,745$131.59Sell$4,835,274.55
Dec. 20, 2017SVP6,249$121.20Sell$757,378.80
Dec. 1, 2017SVP30,000$135.89Sell$4,076,700.00
Nov. 22, 2017CEO73,415$130.90Sell$9,610,023.50
Nov. 15, 2017CEO74,000$126.86Sell$9,387,640.00
Nov. 2, 2017Director20,000$130.00Sell$2,600,000.00
Oct. 30, 2017EVP33,666$121.46Sell$4,089,072.36
Oct. 2, 2017President85,316$125.00Sell$10,664,500.00
Sept. 20, 2017President76,815$100.00Sell$7,681,500.00
May 31, 2017Major Shareholder297,501$71.87Buy$21,381,396.87
May 30, 2017SVP11,500$65.35Buy$751,525.00
May 23, 2017EVP11,000$75.00Sell$825,000.00
May 16, 2017VP9,375$70.00Sell$656,250.00
May 15, 2017SVP43,750$65.00Sell$2,843,750.00
Jan. 25, 2017Director15,000$37.95Sell$569,250.00
Jan. 18, 2017Director15,000$37.83Sell$567,450.00
Nov. 30, 2016CMO29,165$44.99Sell$1,312,133.35
Oct. 13, 2016Director27,900$37.00Buy$1,032,300.00
July 20, 2016CEO30,151$64.69Sell$1,950,468.19
April 20, 2016CEO30,151$67.46Sell$2,033,986.46
March 9, 2016Director2,000$58.36Buy$116,720.00
Feb. 22, 2016SVP1,000$62.75Buy$62,750.00
Feb. 1, 2016Major Shareholder205,030$69.75Buy$14,300,842.50
Jan. 20, 2016CEO30,152$71.78Sell$2,164,310.56
Dec. 4, 2015Director30,000$109.00Sell$3,270,000.00
Dec. 2, 2015CEO58,689$104.87Sell$6,154,715.43
Nov. 20, 2015CEO58,690$102.88Sell$6,038,027.20
Nov. 12, 2015Director75,000$103.89Sell$7,791,750.00
June 16, 2015CMO8,750$128.83Sell$1,127,262.50
May 12, 2015Director2,000$112.16Buy$224,320.00
April 21, 2015Director10,000$130.02Sell$1,300,200.00
March 19, 2015Director5,000$120.00Sell$600,000.00
March 17, 2015CMO8,750$116.86Sell$1,022,525.00
Jan. 29, 2015Major Shareholder97,118$95.00Buy$9,226,210.00
Jan. 26, 2015Director1,000$95.00Buy$95,000.00
Jan. 26, 2015CEO10,000$95.00Buy$950,000.00
Dec. 19, 2014COO11,200$100.00Sell$1,120,000.00
Dec. 16, 2014EVP10,626$93.60Sell$994,593.60
Dec. 15, 2014VP22,162$97.50Sell$2,160,795.00
Nov. 18, 2014SVP10,000$90.67Sell$906,700.00
Nov. 17, 2014COO33,200$89.63Sell$2,975,716.00
Oct. 28, 2014Director15,000$95.00Sell$1,425,000.00
Oct. 22, 2014Director5,000$90.00Sell$450,000.00
Oct. 13, 2014Director110,000$85.00Sell$9,350,000.00
Sept. 25, 2014Director90,000$78.09Sell$7,028,100.00
Sept. 24, 2014Director45,000$79.08Sell$3,558,600.00
  • Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.

  • The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Laurie Keating, Barry E Greene, Yvonne Greenstreet, Michael Mason, Philip A Sharp, Paul Schimmel, Laurence Reid, Steven M Paul, Sanofi, Dennis A Ausiello, Tolga Tanguler, Kevin P Starr, Michael W Bonney, Phillip A Sharp, David-Alexandre C Gros, Kevin P. Starr, David E I Pyott, Marsha Fanucci, Philip A. Sharp, and John Clarke

  • The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.

  • John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.

  • Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.

  • The most recent insider trade for Alnylam Pharmaceuticals Inc was on Aug. 5, 2022.

  • The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.

  • The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Akshay Vaishnaw with a total value of $12,672,077.40 on March 14, 2018.